All lobbying filings

DLA PIPER LLP (US)

Lobbying for INDIVIOR INC. · Pharmaceutical company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Virginia · Senate · $60,000.00 income · posted Oct 16, 2025

Official filing document

Lobbying activity 2

Medicare/Medicaid

Medicaid Reentry Act, policies related to reimbursement of substance use disorder treatment.

Health Issues

General education on issues related to the Drug Enforcement Agency (DEA). Issues related to substance use addiction and treatment, including NIH/HHS funding levels.Issues related to access to addiction treatments, including telehealth.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.